1. Identification of a Glypican-3-Binding Peptide for In Vivo Non-Invasive Human Hepatocellular Carcinoma Detection
   Zainen Qin et al, 2017, Macromol. Biosci. CrossRef
2. Targeted and Multifunctional Technology for Identification between Hepatocellular Carcinoma and Liver Cirrhosis
   Han Deng et al, 2019, ACS Appl. Mater. Interfaces CrossRef
3. The Expression of Glypican-3 in Colorectal Cancer
   Sonia Azizpour et al, 2019, Cytol. Genet. CrossRef
4. Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma
   Meghan M. Bell et al, 2020, Molecules CrossRef
5. Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment
   Mengtao Xing et al, 2021, IJMS CrossRef
6. Multi-Modal Imaging Probe for Glypican-3 Overexpressed in Orthotopic Hepatocellular Carcinoma
   Shuo Feng et al, 2021, J. Med. Chem. CrossRef
7. Critical Investigation of the Usability of Hepatoma Cell Lines HepG2 and Huh7 as Models for the Metabolic Representation of Resectable Hepatocellular Carcinoma
   Gerda Schicht et al, 2022, Cancers CrossRef
8. Elucidation of the Usefulness of Glypican-3, a Hepatocellular Carcinoma Biomarker, with the Fully Automated LUMIPULSE^® System
   Hisashi Nojima et al, 2023 CrossRef
9. Immunohistochemical panel of glypican-3, hepatocyte paraffin antigen-1, arginase-1, cytokeratin-19, and human epithelial membrane antigen for the differential diagnosis of liver tumors
   Dongling Zhu et al, 2019 CrossRef
10. Association between air pollution and primary liver cancer in European and east Asian populations: a Mendelian randomization study
    Mengting Sun et al, 2023, Front. Public Health CrossRef